Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quality of Life and Nutritional Improvements in Cirrhotic Patients Following Hepatic Encephalopathy Using Rifaximin.

NCT01842113 is registered in ClinicalTrials.gov with Tampa General Hospital as lead sponsor.

NCT NCT01842113
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01842113 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quality of Life and Nutritional Improvements in Cirrhotic Patients Following Hepatic Encephalopathy Using Rifaximin.
Lead sponsor
Tampa General Hospital
Phase
Phase 4
Overall status
Terminated
Start date
April 30, 2013
Completion date
Not reported
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic encephalopathy, liver cirrhosis, portal hypertension